About Glycosylated lysosomal membrane protein
Glycosylated lysosomal membrane protein (GLMP) is a protein
from Homo sapiens identified by UniProt accession
Q8WWB7, 406 residues long.
MolForge cross-references it against 0 known binders and
149 disease associations.
Target properties
| Protein name | Glycosylated lysosomal membrane protein |
| UniProt accession | Q8WWB7 |
| Gene | GLMP |
| Organism | Homo sapiens |
| Length | 406 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (149)
Diseases linked to this target (Open Targets).
- basophil count · score 0.09
- mean corpuscular hemoglobin concentration · score 0.09
- HbA1c measurement · score 0.09
- mean corpuscular volume · score 0.08
- head and neck squamous cell carcinoma · score 0.07
- erythrocyte count · score 0.07
- hemoglobin measurement · score 0.07
- serum albumin measurement · score 0.07
- red blood cell density measurement · score 0.06
- hemoglobin A1 measurement · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8WWB7-F1 | alphafold | PREDICTED | 86.36 | — |
Amino-acid sequence (406 residues)
MRGSVECTWG WGHCAPSPLL LWTLLLFAAP FGLLGEKTRQ VSLEVIPNWL GPLQNLLHIR AVGTNSTLHY VWSSLGPLAV VMVATNTPHS TLSVNWSLLL SPEPDGGLMV LPKDSIQFSS ALVFTRLLEF DSTNVSDTAA KPLGRPYPPY SLADFSWNNI TDSLDPATLS ATFQGHPMND PTRTFANGSL AFRVQAFSRS SRPAQPPRLL HTADTCQLEV ALIGASPRGN RSLFGLEVAT LGQGPDCPSM QEQHSIDDEY APAVFQLDQL LWGSLPSGFA QWRPVAYSQK PGGRESALPC QASPLHPALA YSLPQSPIVR AFFGSQNNFC AFNLTFGAST GPGYWDQHYL SWSMLLGVGF PPVDGLSPLV LGIMAVALGA PGLMLLGGGL VLLLHHKKYS EYQSIN
Explore Glycosylated lysosomal membrane protein with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets